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Monocytes infected with feline infectious peritonitis virus, a coronavirus, express viral proteins in their plasma membranes.
Upon binding of antibodies, these proteins are quickly internalised through a new clathrin- and caveolae-independent
internalisation pathway. By doing so, the infected monocytes can escape antibody-dependent cell lysis. In the present
study, we investigated which kinases and cytoskeletal proteins are of importance during internalisation and subsequent
intracellular transport. The experiments showed that myosin light chain kinase (MLCK) and myosin 1 are crucial for the
initiation of the internalisation. With co-localisation stainings, it was found that MLCK and myosin 1 co-localise with
antigens even before internalisation started. Myosin 6 co-localised with the internalising complexes during passage
through the cortical actin, were it might play a role in moving or disintegrating actin filaments, to overcome the actin
barrier. One minute after internalisation started, vesicles had passed the cortical actin, co-localised with microtubules
and association with myosin 6 was lost. The vesicles were further transported over the microtubules and accumulated
at the microtubule organising centre after 10 to 30 min. Intracellular trafficking over microtubules was mediated by
MLCK, myosin 1 and a small actin tail. Since inhibiting MLCK with ML-7 was so efficient in blocking the internalisation
pathway, this target can be used for the development of a new treatment for FIPV.Introduction
Two genetically highly similar biotypes of coronaviruses
are described in cats: feline infectious peritonitis virus
(FIPV) and feline enteric coronavirus (FECV). These
coronaviruses can infect both cats and other members
of the Felidae family. An infection with FECV is usually
sub-clinical, except in young kittens where it may cause
mild to severe diarrhoea [1]. In contrast, FIPV infection
causes a chronic and very often fatal pleuritis/peritonitis.
In fact, it is the most important cause of death of infectious
origin in cats. Cats with clinical FIP often have very high
titers of FIPV-specific antibodies. Yet, these antibodies are* Correspondence: Hans.Nauwynck@UGent.be
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distribution, and reproduction in any mediumnot able to block infection, which suggests that antibodies
and antibody-driven immune effectors are not able to
efficiently clear the body from virus and/or virus-infected
cells.
In previous work, we presented some immune evasion
strategies used by FIPV that could clarify why antibodies
seem to be unable to identify infected cells and/or mark
them for antibody-dependent cell lysis. We found that
only half of the infected monocytes express viral proteins
on their surface [2]. In the cells that do express viral
proteins, these proteins are internalised upon antibody
addition through a highly efficient and fast process
resulting in FIPV-infected cells without visually detectable
viral proteins on their plasma membrane [3]. The fact
that no viral antigens can be found on FIPV infectedtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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this expression returns after in vitro cultivation, is a strong
indication that this immune evasion strategy occurs
in vivo [4]. We then went on to elucidate through which
internalisation pathway these antigen-antibody complexes
are internalised.
Ligands can be internalised into cells via several pathways.
There are 4 “classical” pathways: phagocytosis, macropi-
nocytosis, clathrin-mediated internalisation and caveolae-
mediated internalisation (for extensive reviews readers are
referred to [5-11]) and 5 less well defined “non-classical”
pathways. These latter pathways are distinguished from
one another by their dependence on rafts, dynamin and
Rho-GTPases. Two pathways are dependent on dynamin.
A first pathway is used by the interleukin 2 (Il2) receptor
for uptake of Il2 in leukocytes and is dependent on rafts
and (an) unidentified Rho-GTPase(s) [12]. This pathway
might also be used by cellular prion proteins [13]. A
second dynamin-dependent non-classical pathway is
actin and Rho-kinase dependent but independent of
rafts and is used by intracellular adhesion molecule-1
and platelet-endothelial cell adhesion molecule-1 [14].
Of the 3 dynamin-independent pathways, 1 is dependent
on rafts and Cdc42 (a Rho-GTPase) and is utilised by GPI-
anchored proteins; like the folate receptor [15,16]. Another
dynamin-independent pathway is used by Menkes disease
ATPase (ATP7a), a defective copper transporting ATPase
and is also independent from rafts but is regulated by Rac1
(a Rho-GTPase) [17]. The third dynamin-independent in-
ternalisation pathway was presented in our previous work
and is the pathway through which viral surface expressed
proteins in FIPV infected monocytes are internalised.
This pathway, the fifth non-classical pathway, occurs in-
dependently from rafts, dynamin and rho-GTPases [18].
Surely more pathways await their discovery.
Once internalised, these vesicles need active trans-
portation to get through the dense, protein rich cytosol
and around cytoskeleton components towards their final
destination. Long-range transport to get from the cell
periphery to the cell centre runs over microtubules and is
mediated by the motor proteins dynein and kinesin.
Transport in the cell periphery and short-range transport
inside the cell is mediated by actin and its associated
motor proteins, myosins. Endosomes can be pushed
forward by polymerising actin filaments forming an
“actin tail” or can be transported by myosins over actin
filaments. Formation of actin tails has been described in a
variety of internalisation pathways. After phagocytosis,
movement of phagosomes is mediated by actin tails in
macrophages and Dictyostelium [19-21]. Also macropi-
nosomes are propelled by an actin tail towards the cell
centre [22,23]. In clathrin-mediated internalisation, actin
has been implicated in several steps of the internalisation
process in both mammalian and yeast cells [24-26].However, actin requirements seem to be dependent on
cell type and experimental conditions [27]. Formation of
an actin tail is seen in 80% of clathrin-coated pit internal-
isation events but only during initial movement [10,24,25].
Small actin tails polymerise on caveolae shortly after
internalisation induced by Simian Virus 40 (SV40) [28].
Actin comet tails have also been reported on endosomes
and lysosomes in HeLa cells, cultured mast cells, NIH
3 T3 cell, budding yeast and Xenopus eggs [29-32]. Move-
ment that is mediated by such an actin tail has no defined
direction nor does it run over actin tracks. In contrast,
transport mediated by myosin motors runs over actin fila-
ments in a direction dictated by the myosin. Myosins from
classes I, II, V, VI, VII, XI and X are known to play a role
during one or more internalisation pathways [33]. How-
ever, these myosins are mainly associated with the first
steps of internalisation being membrane remodelling and
pinching off of the vesicles. So far, there are few reports
on the role of myosins in trafficking of endosomes. In
mouse hepatoma cells, myosin 1α (Myo1α) (an analogue
of human myosin 1b) contributes to the trafficking of
lysosomes along microtubules [34,35]. Myosin 6 trans-
ports recently uncoated vesicles through the cortical
actin barrier after clathrin-mediated internalisation in
non-polarised epithelial cells [36,37]. Myosin 5 plays a
role in outbound trafficking of secretory vesicles [33].
The aim of this study was to clarify how this recently
characterised pathway used by surface expressed antigens
in FIPV infected monocytes, was regulated and which role
is played by microtubules, actin and myosins during and
after internalisation. The experiments showed that myosin
light chain kinase (MLCK), myosin 1, myosin 6, microtu-
bles and actin are involved in antibody-induced internalisa-
tion in FIPV infected monocytes.
Materials and methods
Viruses and antibodies
A third passage of FIPV strain 79–1146 (American Type
Culture Collection (ATCC)) on CrFK cells was used [38].
FIPV strain 79–1146 is a type 2 strain which is studied
extensively even though type 1 strains are predominant
in the field. This is because type 2 coronaviruses are easily
propagated in vitro. Polyclonal anti-FCoV antibodies were
kindly provided by P. Rottier (Utrecht University, The
Netherlands). The antibodies were purified and biotinyl-
ated according to manufacturers instructions (Amersham
Bioscience, Buckinghamshire, UK). FITC-labelled polyclonal
anti-FIPV antibodies were purchased from Veterinary
Medical Research and Development (VMRD, Pullman,
Washington, USA). The monoclonal antibody E22-2 recog-
nising the N protein, was kindly provided by T. Hohdatsu
(Kitasato University, Japan). The monocyte marker DH59B,
recognising CD172a, was purchased from VMRD. Rabbit
anti-tubulin polyclonal antibodies and monoclonal antibodies
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Abcam (Cambridge, UK), rabbit polyclonal antibodies
against non-muscle myosin 2a, 2b and 9b from Sigma-
Aldrich (Steinheim, Germany) and goat polyclonal against
MLCK and rabbit polyclonal antibodies against myosin 5a,
6, 7a and 10 from Santa Cruz Biotechnology (Santa Cruz,
California, USA). Secondary antibodies and reagents: goat
anti-mouse Texas Red, goat anti-mouse Alexa Fluor 350,
streptavidin Texas Red, streptavidin FITC, streptavidin
Alexa fluor 405, anti-rabbit Alexa Fluor 594 Zenon re-
agent were purchased from Molecular Probes (Molecular
Probes-Invitrogen, Eugene, Oregon, USA).
Isolation and inoculation of blood monocytes
Feline monocytes were isolated as described previously
[2]. Cells were seeded on glass coverslips inserted in a
24-well dish (Nunc A/S, Roskilde, Denmark) in RPMI-
1640 medium containing 10% fetal bovine serum (FBS),
0.3 mg/mL glutamine, 100 U/mL penicillin, 0.1 mg/mL
streptomycin, 0.1 mg/mL kanamycin, 10 U/mL heparin,
1 mM sodium pyruvate, and 1% non-essential amino-
acids 100× (GIBCO-Invitrogen, Merelbeke, Belgium).
Non-adherent cells were removed by washing the dishes
two times with RPMI-1640 at 2 and 24 h after seeding.
The adherent cells consisted for 86 ± 7% of monocytes
(as assessed by fluorescent staining with the monocyte
marker DH59B). At 56 h post seeding, monocytes were
inoculated with FIPV at a multiplicity of infection of 5.
Between 20 and 60 cells were analysed per assay.
Internalisation inhibition assays
Twelve hours after inoculation, monocytes seeded on glass
coverslips were pre-incubated for 30 min at 37 °C with 5%
CO2 in the presence of one of the following agents dis-
solved in RPMI: 20 μM Latrunculin B (ICN Biochemicals
Inc., Ohio, USA), 50 μM Cytochalasin D (Sigma-Aldrich
GmbH, Steinheim, Germany), 50 nM Jasplakinolide (Mo-
lecular Probes), 500 μM Colchicine (Sigma-Aldrich GmbH),
20 μM Nocodazole (Sigma-Aldrich GmbH), 5 μM Pacli-
taxel (Calbiochem, San Diego, California, USA), 500 nM
Bisindolylmaleimide (Calbiochem), 10 μM ML-7 (Calbio-
chem), 500 nM H-89 (Calbiochem), 3 μM KN-93 (Calbio-
chem), 200 μM PKG inhibitor (Calbiochem), 150 nM
K-252a (Calbiochem) and 40 μM Blebbistatin (Sigma-
Aldrich GmbH). The working concentration of each re-
agent was based on literature values and was optimised
qualitatively in internalisation assays with control ligands
(data not shown). Viability of the cells during the inhibition
assay was tested for each inhibitor using ethidium bromide
monoazide (Molecular Probes-Invitrogen) and was always
over 99%.
After pre-treatment, the cells were incubated with
polyclonal biotinylated anti-FIPV antibodies in presence of
one of the given inhibitors for 30 min at 37 °C. Then, cellswere fixed with 1% formaldehyde, permeabilized with
0.1% Triton X-100 (Sigma-Aldrich GmbH) and incubated
with streptavidin-Texas Red for 1 h at 37 °C. Next, in-
fected cells were visualised with polyclonal anti-FIPV-
FITC. The glass coverslips were mounted on microscope
slides using glycerine-PBS solution (0.9:0.1, vol/vol)
with 2.5% 1,4-diazabicyclo(2,2,2)octane (DABCO)
(Janssen Chimica, Beerse, Belgium) and analysed with
confocal microscopy. Percentages of cells with fully inter-
nalised complexes were calculated relative to the total
amount of monocytes which showed antibody binding
and thus had membrane expression before antibodies
were added. Those monocytes constitute about 50% of the
total amount of infected cells [2]. Because of the variabil-
ity on the amount of cells with membrane expression,
visualisation of the complexes remaining at the plasma
membrane was needed. Therefore, an acid washing step
to remove the extracellular antibodies was not performed.
To test the effectiveness of all reagents, a suitable control
was used in each experiment. Monocytes seeded on glass
coverslips were pre-incubated for 30 min at 37 °C with
5% CO2 in the presence of one of the inhibitors. After
treatment, the cells were incubated with biotinylated
transferrin (Sigma-Aldrich GmbH) or fluorescent 1 μm
polystyrene microspheres, FluoSpheres (Molecular Probes-
Invitrogen), in presence of the inhibitor. Then, all cells were
fixed with 1% formaldehyde and permeabilized with 0.1%
Triton X-100. The biotinylated transferrin was visualised by
incubating the cells with streptavidin-FITC for 1 h at 37 °C
and cells incubated with fluorescent beads were incubated
with phalloidin-Texas Red (Molecular Probes-Invitrogen)
for 1 h at 37 °C to visualise the lamellipodia. The glass
coverslips were mounted on microscope slides using
glycerine-DABCO and analysed by confocal microscopy.
For the controls, the monocytes were scored analogously
as FIPV-infected cells: ligands were considered “fully inter-
nalised” when they were only observed inside the cell.
Fluorescent beads were considered internalised when they
were found inside the cortical actin labelling.
Co-localisation studies with MLCK, myosins, actin
filaments or microtubules
Twelve hours after inoculation, monocytes were incubated
with biotinylated anti-FIPV polyclonal antibodies. At dif-
ferent times post antibody addition, cells were fixed with
1% formaldehyde, permeabilized with 0.1% Triton X-100
and antigen-antibody complexes were visualised with
streptavidin-FITC followed by a blocking step with 10%
negative goat serum. Next, actin filaments, microtubules,
MLCK or myosins were stained. Cells were incubated with
phalloidin-Texas Red to visualise actin filaments. To stain
the microtubules, polyclonal rabbit anti-tubulin antibodies
were tagged with anti-rabbit Alexa Fluor 594 Zenon re-
agent. To visualise MLCK, a goat polyclonal was used,
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myosin 1, monoclonal anti-myosin 1 was used, followed
by goat anti-mouse Texas Red. To visualise other myosins,
rabbit anti-myosin 2a, 2b, 5a, 6, 7a, 9b and 10 was tagged
with anti-rabbit Alexa Fluor 594 Zenon reagent. After
45 min of incubation, cells were fixed to stabilise the
Zenon reagent. Finally, infected cells were visualised with
monoclonal anti-N and goat anti-mouse Alexa Fluor 350
(not shown in images).
For the colocalisation of myosin 1 and MLCK during the
internalisation process, infected monocytes were incubated
with anti-FIPV polyclonal antibodies. At different times
post antibody addition, cells were fixed with 1% formalde-
hyde, permeabilized with 0.1% Triton X-100 and MLCK
was visualised with goat anti-MLCK, biotinylated donkey
anti-goat and streptavidin Alexa fluor 405 (with negative
goat serum to block). Then myosin 1 was visualised with
mouse anti-myosin 1 and goat anti-mouse Texas Red. The
internalising antigen-antibody complexes were visualised
with goat anti-cat FITC.
Confocal laser scanning microscopy
The samples were stained as described above and examined
with a Leica TCS SP2 or SPE laser scanning spectral
confocal system (Leica Microsystems GmbH, Wetzlar,
Germany) linked to a DM IRB inverted microscope (Leica
Microsystems). Argon and Helium/Neon laser lights were
used to excite FITC (488 nm line) and Texas Red (543 nm
line) fluorochromes, the violet diode laser was used to
excite Alexa Fluor 405 (405 nm line). The images were
obtained with Leica confocal software and processed
with the GIMP.
Statistical analysis
Triplicate assays were compared using a Mann-Withney U
test with SPSS 11.0 (SPSS Inc., Chicago, WA). P values <
0.05 were considered significantly different.
Results
Internalisation of viral antigens is regulated by myosin
light chain kinase but not by myosin 2
The serine/threonine kinases are the biggest group of
kinases and consist of different classes among which:
protein kinase C (PKC), protein kinase A (PKA) or cyclic
AMP-dependent protein kinases, protein kinase G (PKG)
or cyclic GMP-dependent protein kinases, the family of
the calcium/calmodulin-dependent protein kinases (CaMK)
and myosin light chain kinases (MLCK). The importance of
these classes was tested by performing internalisation assays
in the presence of pharmacological inhibitors. PKC is
known to regulate Fc receptor-, complement receptor- and
mannose receptor-mediated phagocytosis [6]. PKA and
MLCK were shown to mediate phagocytosis in neutrophils
[39]. So for the inhibition of these targets, fluorescent beadswere chosen as a control ligands. PKC is known to regulate
Fc receptor-, complement receptor- and mannose receptor-
mediated phagocytosis [6]. PKA and MLCK were shown to
mediate phagocytosis in neutrophils [39].
The internalisation of viral antigens remained unaffected
in the presence of bisindolylmaleimide I (a PKC-inhibitor),
H-89 (a PKA-inhibitor), PKG-inhibitor and KN-93 (a
CaMK II-inhibitor) while the internalisation of a control
ligand was reduced to 25 ± 13%, 33 ± 29%, 14 ± 7% and
23 ± 16% respectively (representative images and results
are given in Figure 1). Additionally, it was confirmed
that not the infection itself nor the presence of antibodies
to induce internalisation affected the activity of inhibitors
directed against the major internalisation pathways (data
not shown). In contrast, the specific MLCK inhibitor
ML-7, could inhibit the internalisation of viral antigens
to 12 ± 21% of the untreated control and the uptake of
beads, the control ligand, was equivalently reduced to
11 ± 5% (Figure 1). The importance of MLCK was rein-
forced by another MLCK inhibitor: K252a, which also
inhibited the internalisation of both the viral antigens as
the control ligand (beads) to a similar level (Figure 2A
and B). It is described in literature that MLCK regulates
myosin 2 both by phosphorylation of the regulatory light
chain and by binding to it [40,41]. Thus, an additional
internalisation inhibition assay was performed with bleb-
bistatin, a myosin 2 inhibitor, to investigate the involve-
ment of myosin 2. The test indicated that internalisation
of the antigen-antibody complexes could not be blocked
by blebbistatin, while the uptake of beads could (Figure 2A
and B), indicating that myosin 2 is not involved in the
internalisation process. This was further investigated
with co-localisation stainings of the antigen-antibody
complexes with myosin 2a and 2b and MLCK. Figure 2C
shows that no indication of a role for myosin 2a nor 2b
were found while MLCK clearly colocalized already before
the addition of antibodies (see Figure 2C). MLCK remained
associated with the viral antigen-antibody complexes at
least until 10 min after antibody addition. After 30 min,
the association was lost.
Co-localisation of viral antigen-antibody complexes,
myosins and MLCK
Since the experiments suggested that myosin 2 is not
involved in the internalisation process, it was further
investigated which myosin is involved. Myosin 1, 5a, 6,
7a, 9b and 10 were selected based on their role during
several internalisation processes. During the internalisa-
tion experiments, no co-localisation was found between
myosin 5a, 7a, 9b and 10 and the viral antigens at any time
point (data not shown). In contrast, viral antigens did
co-localise with myosin 1 and 6. Similar to MLCK in the
previous experiment, myosin 1 was highly enriched at
the plasma membrane, right underneath the viral proteins
AB
Figure 1 Myosin light chain kinase inhibitors can block the internalisation of surface expressed viral antigens. A range of serine/threonine
kinases were tested for their importance during the internalisation process using chemical inhibitors: Bisindolylmaleimide (PKC inhibitor), H-89 (PKA
inhibitor), PKG inhibitor, KN-93 (CaM-dependent kinase II inhibitor), ML-7 (MLCK inhibitor). (A) Confocal images of feline monocytes after an internalisation
assays of 30 min using antibodies or control ligands: beads or transferrin. In row 2, cortical actin was stained (red) to visualise whether or not the
lamellipodia were closed around the beads. The images show a single optical section through the cell, scale bar indicates 5 μm. (B) Quantification of
the internalisation in presence of inhibitors against serine/threonine kinases. Results are given relatively to a control of untreated cells. Data are means
and standard deviations of triplicate assays. The asterisk marks results that are significantly different from the untreated control (p < 0.05).
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bodies were added. Then, shortly after addition of the
antibodies, myosin 1 relocated between the internalised
complex and the plasma membrane (see panel b-zoom of
Figure 3A). As the antigen-antibody complexes moved
further into the cell, they maintained their association
with myosin 1. At 10 min after antibody addition, a loss
of interaction was first observed (e.g. in the centre of the
cell depicted in panel e of Figure 3A). Further dissociation
of myosin 1 from the internalised complexes occurred as
time passed and vesicles reached the centre of the cell.
Co-localisation with myosin 6 was also observed as
quickly as 30 s after addition of the antibodies when
antigen-antibody complexes were right under the plasmamembrane (see panel h1-zoom of Figure 3A) but associ-
ation was lost as soon as the viral antigen-antibody com-
plexes moved further inside the cell (illustrated in panel
h2 and h2-zoom of Figure 3A). The images in panel h1
and h2 are actually different sections through the same
cell, which clearly illustrates how short-lived the myosin 6
association with internalised complexes is. At later time
points, cells with co-localisation were still found, but never
below the actin cortex (e.g. panel j-zoom of Figure 3A).
We suggest that those co-localisations represent antigen-
antibody complexes that just started to internalise at the
moment of fixation.
To further test whether or not MLCK could be involved
in the regulation of myosin 1 or 6, it was assessed if
A B
C
Figure 2 The internalisation of antigen-antibody complexes is mediated by MLCK but not myosin 2. (A) Quantification of the internalisation
process in presence of K252-a (inhibits MLCK, PKA, PKC and PKG) and Blebbistatin (inhibits myosin 2) 30 min after addition of antibodies.
Results are given relatively to a control of untreated cells. Data are means and standard deviations of triplicate assays. The asterisk marks results that are
significantly different from the untreated control (p < 0.05). (B) Confocal images of monocytes after internalisation in the presence of the inhibitors. The
activity of each inhibitor was tested with internalisation assays of fluorescent beads. In row 2, cortical actin was stained (red) to visualise whether or not
the lamellipodia were closed around the beads. (C) Visualisation of myosin 2a, 2b and MLCK (red) during antibody-induced internalisation of surface
expressed viral antigens (green) in FIPV-infected monocytes at some time points after antibody addition. Arrow heads in the MLCK row indicate
antigen-antibody complexes were colocalisation was lost. All images show a single optical section through a monocyte, scale bar indicates 5 μm.
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complexes in the presence of the MLCK inhibitor ML-7.
The images in Figure 3B show that if cells are treated with
ML-7, the association of the antigen-antibody complexes
with myosin 1 was strongly affected and occurred only in
a small fraction of the complexes. At 30 min post antibody
addition, a small fraction remains associated with myosin
1. However, these complexes did not internalise. When
myosin 6 was stained in cells pretreated with ML-7, no as-
sociation could be seen before antibody addition (similar
as in untreated cells). At 30 min post antibody addition, a
substantial amount of association was seen, so the call for
myosin 6 seemed intact. Since ML-7 effectively inhibits
internalisation, mere association with myosin 1 and/or 6 is
not enough for their function.
Since the pattern of the myosin 1 association with the
internalising antigen-antibody complexes resembles theMLCK pattern and the previous experiment indicated
that recruitment of myosin 1 was most affected by the
inhibition of MLCK, a co-localisation staining of the
antigen-antibody complexes, myosin 1 and MLCK was
done. Figure 4 confirms that the internalising complexes,
myosin 1 and MLCK fully co-localize before and during
the initial steps of the internalisation process. At 30 min
post antibody addition, vesicles appear which still carry
myosin 1, but MLCK association was lost. This is probably
shortly before the association with myosin 1 is also lost, as
was seen in Figure 3A. These results further confirm that
MLCK might be regulating myosin 1.
The role of actin in internalisation of viral antigen-antibody
complexes
As myosins are involved in the internalization process,
the tracks of these motor proteins, actin filaments, may
AB C
Figure 3 The role of myosin 1 and 6 during the internalisation of viral antigens. (A) Confocal images of the internalisation process at
different times post antibody addition, in which the antigen-antibody complexes was visualised with FITC (green signal). Myosins were visualised
in red with Texas Red (Myo1) or Alexa Fluor 594 (myo6). (B + C) The effect of ML-7 on the recruitment of myosin 1 (B) or myosin 6 (C) in the
internalisation of antigen-antibody complexes. Cells were pretreated with ML-7 for 30 min. Cells were fixed before or 30 min after antibody addition.
Antigen-antibody complexes were visualised in green and myosin in red. Arrowheads indicate colocalisation of myosins with antigen-antibody
complexes. All images show a single optical section through the cell. Scale bars represent 5 μm.
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this internalisation pathway, internalisation assays were
performed in presence of the inhibitors Cytochalasin D
(which inhibits formation of new filaments), Latrunculin
B (which disrupts all actin filaments) and Jasplakinolide
(which stabilises existing filaments and induces polymer-
isation of new filaments). Figure 5B shows representative
confocal images of monocytes at 30 min after addition
of antibodies in the presence of one of the inhibitors.
Cells treated with Cytochalasin D or Latrunculin B showed
internalised viral antigen-antibody complexes in a pattern
similar to that in the untreated control cells. Monocytes
treated with Jasplakinolide also internalised viral antigen-
antibody complexes, however, the typical pattern of
randomly distributed internalised complexes was not
observed. Fewer internalised vesicles seemed to travel as
far into the cell as in untreated monocytes or in mono-
cytes treated with Cytochalasin D or Latrunculin B. In
monocytes treated with Jasplakinolide, one can expect a
cortical actin network that might even be more extensive
than in untreated cells because of the polymerisationinducing capacity of the drug. Nevertheless, almost no
filamentous actin can be seen in the image of the monocyte
trying to internalise a fluorescent bead in Figure 5B. The
reason for this apparent discrepancy is that Jasplakinolide
impedes phalloidin-Texas Red from binding to actin
filaments resulting in a vaguely red cell even though a
cortical actin network is present.
The quantification of the internalisation in the pres-
ence of inhibitors confirmed that Cytochalasin D and
Latrunculin B did not have a significant effect on the
internalisation process, while both inhibitors strongly
reduced phagocytosis of fluorescent beads to respectively
14 ± 4% and 18 ± 6% of the untreated control (Figure 5A).
These results suggest that actin filaments are not required
for the internalisation process. Treatment of monocytes
with Jasplakinolide gave a small but significant reduction
in internalisation (76 ± 15% of the untreated control),
suggesting that a stabilised cortical actin network might
hamper or slow down the internalisation of antigen-
antibody complexes. Since the internalisation process
could not be blocked by disruption of actin filaments
Figure 4 Colocalisation staining of antigen-antibody complexes, Myosin 1 and MLCK during the internalisation process. Confocal images of
the internalisation process at different times post antibody addition, in which the antigen-antibody complexes was visualised with FITC (green signal),
myosin 1 with Texas Red (red) and MLCK with Alexa Fluor 405 (blue). The images show a single optical section through a monocyte. Scale bars
represent 5 μm and arrowheads indicate vesicles which have lost the association of MLCK.
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filaments, it can be concluded that actin does not play
an active role in the internalisation process.
To further elucidate the role for actin during the in-
ternalisation process, actin filaments were visualised
with phalloidin-Texas Red at different times after initiation
of the internalisation. The confocal images in Figure 5C
show that at 1 min after addition of antibodies, antigen-
antibody complexes moved into the cells and at the in-
ternalisation sites a local absence of cortical actin
could be observed. It could be that actin filaments
were moved or broken down in order to make way for
the internalising complexes, which provides an explanation
why Jasplakinolide reduced or slowed down the internalisa-
tion. Another noteworthy observation was made at later
stages of the internalisation process. Figure 5C shows that
vesicles that have passed through the cortical actin network
were still associated with actin in a way that resembles actin
tails. This association of internalised vesicles with actin
was still observed at 10 min after initiation of the internal-
isation, but was lost at 30 min.
By treating the cells with a combination of Latrunculin
B and ML-7, it was investigated if lifting the actin barrier
would be enough to enable internalisation or if MLCK
(and thus myosins) are also required to initiate the intern-
alisation process. It was found that the internalisation in
the presence of both inhibitors was reduced to 3 ± 5%,
which is not significantly different from the inhibition
assay with ML-7 alone, which indicate that active MLCKis required for the initiation of the internalisation process
(see Figure 5D for a cell treated with Latrunculin B and
ML-7 at 30 min post antibody addition).
Taking these results together, MLCK plays a role in
the initiation of the internalisation process. In contrast,
actin might not be required for internalisation, as indicated
by the inhibition assays with Cytochalasin D and Latrun-
culin B. The actin stainings and the results with the actin
stabilising drug Jasplakinolide indicated that the cortical
actin network forms a barrier that can slow down in-
ternalisation and that must be overcome by moving or
disintegrating actin filaments. Additionally, actin and
MLCK may play an active role in further transportation
into the cell since fully internalised complexes were asso-
ciated with actin tails and MLCK.
The role of microtubules in transportation of viral
antigen-antibody complexes into the cell
The primary route for vesicles to move from the plasma
membrane towards the cell centre runs over the microtu-
bules. The internalisation studied here is a very fast and
efficient process. Internalised antigen-antibody complexes
can be found in the centre of the cell as soon as 5 min
after addition of antibodies. In this section we verified if
internalised vesicles are transported over the microtubules
to reach the cell centre. First, internalisation assays were
performed in the presence of one of the following inhibi-
tors: Colchicine, Nocodazole (which both disrupt micro-
tubules) or Paclitaxel (which promotes the assembly and
BA
C D
Figure 5 Role of actin in the internalisation of surface expressed viral antigens in FIPV-infected monocytes. (A) Quantification of the
internalisation of surface expressed viral antigens in the presence of actin inhibitors. Results are given relatively to a control of untreated
cells. Data are means and standard deviations of triplicate assays. The asterisk marks results that are significantly different from the untreated control
(p < 0.05). (B) Confocal images of monocytes after internalisation in the presence of actin inhibitors. The activity of each inhibitor was tested with
internalisation assays of fluorescent beads. In row 2, cortical actin was stained (red) to visualise whether or not the lamellipodia were closed around
the beads. (C) Visualisation of actin dynamics (red) during antibody-induced internalisation of surface expressed viral antigens (green) in FIPV-infected
monocytes at some time points after antibody addition. (D) A confocal image of an infected monocyte at 30 min post antibody addition during
treatment with Latrunculin B and ML-7. All images show a single optical section through a monocyte and the scale bars represent 5 μm.
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Figure 6B show that some internalisation could still occur
in the presence of either inhibitor since antigen-antibody
complexes were observed inside the monocytes. However,
most internalised vesicles remained close to the plasma
membrane indicating that transportation to the centre of
the cell was inhibited. Quantification revealed a decrease
in internalisation when monocytes were treated with
Colchicine or Nocodazole, to 28 ± 15% and 18 ± 3% of the
untreated control respectively (Figure 6A). Thus, not only
transportation was inhibited but internalisation itself as
well. Treatment with Paclitaxel also led to a decrease in
internalisation, albeit less pronounced than with the other
inhibitors (74 ± 15% of the untreated control). Since
Paclitaxel is a drug that stabilises microtubules, these
findings indicate that microtubules must not only be
intact but they must also remain dynamic. Although
the decrease was significantly different, it was minor
compared to the strong reduction in internalisation of
the control ligand transferrin (8 ± 9% of the untreated
control). This indicates that the requirement for dynamic
microtubules is not as stringent in the internalisationpathways studied here as it is in the clathrin-mediated
internalisation of transferrin.
To confirm the role for microtubules in the transporta-
tion of internalised vesicles, microtubules were visualised
during the internalisation process. The confocal images in
Figure 6C show that internalising vesicles were associated
with microtubules as soon as 1 min after initiation of
internalisation, thus microtubule based transport started
most likely right after passage through the cortical actin
network. After 10 min, the first vesicles already reached
the microtubule organising centre (MTOC). Association of
the internalised vesicles with microtubules was maintained
at all tested time points.
Taken together, these findings indicate that antigen-
antibody complexes were transported over the micro-
tubules towards the cell centre and accumulated at the
MTOC.
Discussion
When primary feline monocytes are infected with FIPV
in vitro, a fraction of the expressed spike (S) protein and
membrane (M) protein can be found in the plasma
CA B
Figure 6 Role of microtubules during internalisation of surface expressed viral antigens in FIPV-infected monocytes. (A) Quantification
of the internalisation in the presence of microtubule inhibitors. Results are given relatively to a control of untreated cells. Data are means and
standard deviations of triplicate assays. The asterisk marks results that are significantly different from the untreated control (p < 0.05). (B) Confocal
images of monocytes after internalisation in the presence of microtubule inhibitors. The activity of each inhibitor was tested with internalisation assays
of transferrin. (C) Visualisation of the microtubules during antibody-induced internalisation of surface expressed viral antigens in FIPV-infected
monocytes. All images show a single optical section through a monocyte and the scale bars represent 5 μm.
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http://www.veterinaryresearch.org/content/45/1/17membrane in half of the infected cells [2]. In contrast,
viral antigens were not detected in the plasma membrane
of monocytes isolated form naturally infected cats [4].
When mimicking the in vivo situation by adding antibodies
to the in vitro culture of FIPV-infected monocytes, we
found that the S and M proteins were quickly and effi-
ciently internalised as heterocomplexes, leaving the
plasma membrane cleared from visually detectable viral
antigens [3]. The internalisation of these antigen-antibody
complexes occurred via a new clathrin- and caveolae-
independent pathway which did not require dynamin,
rafts nor rho-GTPases. Since the antigen-antibody com-
plexes are internalised and transported towards the cell
centre so rapidly, we wanted to investigate how the intern-
alisation process was initiated and the intracellular trans-
port was organised.
The importance of myosin motors during internalisation
is best studied in phagocytosis where Myosin 1, 2, 5, 7, 9b
and 10 cooperate from start to completion of the process
[42-48]. The role for myosins in other internalisation
processes is less well established. Myosin 1 has been as-
sociated with macropinocytosis and clathrin-mediated in-
ternalisation [49,50] and myosin 6 with clathrin-mediated
internalisation [36,51]. The co-localisation stainings withmyosin 1 of the internalisation process studied here, sug-
gest that this myosin might be the driving force behind the
membrane invagination. It has been described that Myosin
1E (formerly known as 1C) might indeed couple poly-
merizing actin to membranes and thus mediate force
production during endocytosis through constraining (and
possibly orienting) actin assembly [52,53]. Several studies
mention that myosin 1 is involved in the formation of
internalising vesicles [54,55]. We found that patches of
myosin 1 could be observed under the viral proteins
residing in the plasma membrane. It could be that the
binding of antibodies on the viral proteins induces a
conformational change that exposes a signal sequence
in the cytoplasmatic tail of the protein leading to the
activation of the internalisation machinery.
The co-localisation stainings also indicated a role for
myosin 6 in the first steps of the internalisation process. In
non-polarised epithelial cells, the short isoform of myosin 6
transports recently uncoated vesicles through the actin
barrier [36,37]. If myosin motors are coupled as dimers,
they can mediate directed movement over a filamentous
actin network such as cortical actin [56-58]. In the study
presented here, we used primary monocytes, which are
non-polarised cells containing a cortical actin network. It
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http://www.veterinaryresearch.org/content/45/1/17is highly probable that myosin 6 will perform the same
task here, namely transporting the internalised antigen-
antibody complexes through the cortical actin.
The results further show that MLCK is required for
the internalisation process, as are myosin 1 and 6 but
not myosin 2a nor 2b. In literature it is stated that
MLCK has a substrate specificity restricted to the regula-
tory light chain of myosin 2. However, most research has
been done on muscle cells while MLCKs have been shown
to function differently in non-muscle cells [59]. So, it is
possible that there are members of the MLCK family
that are not restricted to myosin 2. Research by Blue
and colleagues has indeed shown that the 220 kDa non-
muscle MLCK isoform does not co-localise with myosin
2a nor 2b, while it did co-localise with actin filaments
[60]. Our results hint towards the existence of an MLCK
isoform that regulates myosin 1. This is suggested by (1)
the co-localisation kinetics in which myosin 1 co-localises
with the visualised MLCK isoform before and during
the internalisation process, (2) the finding that recruit-
ment of myosin 1 to the antigen-antibody complexes is
hampered by treatment with ML-7. This inhibitor
blocks the catalytic activity of MLCK, preventing the
phosphorylation of its substrate: myosin [61], and (3)
the finding that myosin 1 and MLCK are already associ-
ated with the viral antigens before addition of antibodies
and thus before internalisation, indicates that mere
binding of MLCK is not enough but its kinase activity is
of importance.Figure 7 Model of the clathrin- and caveolae independent internalisa
antigens in FIPV-infected monocytes. In this figure, the data obtained in
model of the internalisation pathway followed by the antigen-antibody coWhen the role for actin was investigated, it was found
that in the internalisation pathway studied here, dynamic
actin was not a prerequisite. This hypothesis is further
corroborated by the co-localisation stainings which clearly
show that the cortical actin network forms a barrier that
must be moved aside or locally degraded to allow the
internalising vesicle to pass through. Similar observations
have been made during clathrin-or caveolae-mediated
internalisation [27,37,62]. In the internalisation process
that was studied here, myosin 1 and/or 6 could play a
role in moving the cortical actin, but this is not the only
role for (at least) myosin 1 since taking away the cortical
actin in an ML-7 treated, thus MLCK inactive, cell did not
enable internalisation. This, combined with the finding
that myosin 1 is already associated with the antigens
before antibody binding, strongly suggests that myosin
1 is required for the initial steps of the internalisation
process, e.g. membrane remodelling.
Once passed through, the internalised vesicles are fur-
ther transported over microtubules. The track switch from
actin to microtubules might be mediated by myosin 6 [63].
As soon as the vesicles move over the microtubules, asso-
ciation with myosin 6 was lost while association with my-
osin 1 was maintained. It could be that myosin 1 and actin
filaments cooperate with microtubules during intracellular
trafficking. Similar observations have been made in mouse
hepatoma cells where myosin 1α (an analogue of human
myosin 1b) contributes to the trafficking of lysosomes
along microtubules by controlling the directionality of thetion pathway used for antibody-induced internalisation of viral
this publication and previous work has been compiled in to one
mplexes upon binding of specific antibodies.
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the existence of motor complexes that combine actin- and
microtubule-based transport although efforts are focused
on Myosin 5-mediated outbound trafficking [63,64]. Stud-
ies also indicate that myosin 1 controls and constrains
actin polymerisation rather than promoting nucleation
[52,65,66]. The experiments indeed showed that intracel-
lular transport did not require dynamic or polymerising
actin. So, it is possible that the actin tails on the internalis-
ing vesicles are not required for propelling the vesicle but
merely to help in orienting its trafficking towards the cell
centre under the control of myosin 1 which constrains the
actin polymerisation. A hypothetical model combining all
results on the internalisation process, with indication of
endosome markers as was found in previous work, is
given in Figure 7 [18].
From this research, an interesting target for a new
therapy against FIPV arises: MLCK. By inhibiting MLCK
with ML-7, the internalisation process could be efficiently
blocked, which enables the immune system of the host to
recognise and eliminate the infected cells. Such an anti-
immune evasion therapy is a whole new approach to treat
chronic infectious diseases and has some important
advantages over classical anti-viral therapy: (1) A cellular
target is used, hence no problems of drug resistance and
(2) the treatment might be useable for other immune-
evading viruses; (3) It might lead to elimination of the
virus since the virus pools can now be targeted.
In conclusion, the clathrin- and caveolae-independent
internalisation pathway through which surface expressed
viral proteins are internalised after antibody binding in
FIPV-infected monocytes, was initiated and driven by
myosin 1 and MLCK, but did not require actin. The
experiments indicate that myosin 1 might be the driving
force of the internalisation process after activation (phos-
phorylation) by MLCK. During passage through the cortical
actin network, myosin 6 associated with the antigen-
antibody complexes as well. Once passed the cortical
actin, microtubule-based transport started and association
with myosin 6 was lost. During transport over microtu-
bules, the vesicles were associated with small actin tails,
MLCK and Myosin 1, indicating that actin and microtu-
bules cooperate during intracellular trafficking, probably
mediated by Myosin 1. After 10 min, the internalised vesi-
cles reached the microtubule organising centre where they
accumulated and the actin tails, MLCK and myosin 1 asso-
ciations were lost from 30 min on.
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